| Withdrawn | Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus Lower Respiratory Tract Infection | Phase 2 | 2019-02-01 |
| Terminated | Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tra Respiratory Syncytial Virus Lower Respiratory Tract Infection | Phase 2 | 2018-03-01 |
| Completed | Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects. Healthy Volunteers | Phase 1 | 2017-06-05 |
| Completed | Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Respiratory Syncytial Virus Lower Respiratory Tract Infection | Phase 2 | 2017-01-11 |
| Completed | Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura Acquired Thrombotic Thrombocytopenic Purpura | Phase 3 | 2015-11-01 |
| Completed | A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 2 | 2015-07-01 |
| Completed | An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumat Rheumatoid Arthritis | Phase 2 | 2015-07-01 |
| Completed | A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2015-03-01 |
| Completed | A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2015-01-01 |
| Completed | A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Re Respiratory Syncytial Virus Infection | Phase 1 / Phase 2 | 2014-12-01 |
| Completed | Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab. Healthy Volunteers | Phase 1 | 2014-07-01 |
| Completed | ALX-0061 Phase I Bioavailability Study in Healthy Volunteers Rheumatoid Arthritis | Phase 1 | 2014-03-31 |
| Completed | ALX-0171 Safety Study in Adults With Hyperresponsive Airways Respiratory Syncytial Virus Infection | Phase 1 | 2013-07-01 |
| Completed | ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers Healthy, RSV Infection | Phase 1 | 2013-05-01 |
| Completed | ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers RSV Infection | Phase 1 | 2011-11-01 |
| Terminated | First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4 Healthy Volunteers | Phase 1 | 2011-06-01 |
| Completed | Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjec Healthy | Phase 1 | 2011-05-01 |
| Completed | Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA Rheumatoid Arthritis | Phase 1 / Phase 2 | 2011-03-01 |
| Completed | Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thr Acquired Thrombotic Thrombocytopenic Purpura | Phase 2 | 2011-01-01 |
| Completed | A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects Healthy | Phase 1 | 2010-10-01 |
| Completed | Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2010-02-01 |
| Completed | Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 / Phase 2 | 2009-11-01 |
| Completed | Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI Unstable Angina, Non ST Segment Elevation Myocardial Infarction (NSTEMI), Stable Angina (Associated With High Risk PCI) | Phase 2 | 2009-09-01 |
| Completed | Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis Active Rheumatoid Arthritis | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects Healthy | Phase 1 | 2008-11-01 |